company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-728754.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-728754.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6427.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,245982.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-293647.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-769992.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-769152.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2867.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2867.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2867.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-1456153.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1456153.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1456153.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,1456153.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-772019.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1517136.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1517136.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6438.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,53751.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,625828.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-831119.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-831119.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2228634.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2228634.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2228634.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1397515.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1394151.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1394151.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,21030.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,65076.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-155049.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1463094.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1463094.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1800.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2001688.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2003488.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2003488.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3466582.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1127841.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1127841.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7452.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,48985.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-181236.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1252640.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1252640.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2019.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2019.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2019.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1254659.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2351934.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2351934.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7915.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,568831.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,336992.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1438196.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1438196.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1820.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,2003707.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2001887.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2001887.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3313944.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3313944.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3313944.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3877635.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1089186.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1089186.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2801.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-229117.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14211.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1301291.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1301291.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4981.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4981.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4981.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1306272.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-289080.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-289080.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2710.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-731829.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-126156.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1144355.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1144355.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1900.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1900.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1900.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3938303.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3938303.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3938303.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2792048.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2621535.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2621535.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2725.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1386151.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,131725.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1100934.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1100934.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5559952.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5559952.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5559952.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4459017.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-76585.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-76585.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2653.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1214944.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-304910.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1593786.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1593786.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-45500.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7504444.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-6502825.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14052769.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14052769.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,66385.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5016249.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5082634.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5082634.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10563921.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1744289.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1744289.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5364.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,87078.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-597357.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2249204.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2249204.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9433.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2702.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1497445.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1485310.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1485310.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-763894.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3143590.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3143590.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5706.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,543475.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,782185.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1812224.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1812224.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,1.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,2702.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-475468.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2494520.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2021755.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2021755.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,23500.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,23500.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,23500.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,233031.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5912059.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5912059.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5707.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2723266.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1499099.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1683987.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1683987.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3173484.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-1021977.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1855.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4197316.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4197316.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14071694.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3893499.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,17965193.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,17965193.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12083890.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1354658.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1354658.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5706.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1287605.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1493702.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4130259.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4130259.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6805134.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1416.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6806550.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6806550.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,189801.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,189801.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,189801.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10747008.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3811119.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3811119.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5285.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,358644.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1022146.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2425044.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2425044.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-17306.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,983738.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,298615.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1265047.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1265047.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,16504.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,16504.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,16504.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1143493.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3198020.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3198020.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6083.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,246161.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-38084.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2983860.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2983860.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13002.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9014527.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-983738.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-924.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10012191.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10012191.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,26725130.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,26725130.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,26725130.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13729079.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5009892.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5009892.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7235.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1351413.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,98320.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3552924.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3552924.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13119.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,28925.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-749.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15057.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15057.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3537867.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3490030.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3490030.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7971.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-184383.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-313513.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3979955.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3979955.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13896.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,5702.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-749.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8943.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8943.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1821999.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1821999.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1821999.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2166899.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5410259.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5410259.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8148.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1494729.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,112413.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3794969.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3794969.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7910.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34807.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-552.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-43269.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-43269.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,34873869.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1191026.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,36064895.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,36064895.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,32226657.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4558503.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4558503.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8975.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,29939.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,273852.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4245737.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4245737.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1130.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,32305.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-464.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,30711.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,30711.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,113044.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,113044.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,113044.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4101982.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4449038.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4449038.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11259.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-190961.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-714453.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5343193.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5343193.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14425.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-29569.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-424.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-44418.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-44418.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,916617.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,916617.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,916617.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4470994.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5815158.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5815158.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6086.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,186746.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,991004.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4631322.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4631322.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,32071.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18812.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-406.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,50477.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,50477.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,65402.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,65402.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,65402.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4515443.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5386237.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5386237.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13198.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-275387.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-281792.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5930218.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5930218.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-65201.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-370.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-65571.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-65571.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-11265.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-11265.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-11265.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6007054.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4568914.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4568914.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8762.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,204486.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12146.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4343520.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4343520.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-88929.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28062.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,949653.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,832662.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,832662.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3510858.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3953981.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3953981.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9482.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,639150.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,27323.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3278026.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3278026.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-891.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2199915.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2199022.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2199022.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1079004.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4163320.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4163320.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11964.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,381699.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-642082.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4411739.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4411739.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7130.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,25551.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,568031.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,586452.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,586452.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,80251.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,80251.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,80251.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3745036.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4967129.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4967129.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12958.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1151379.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-76083.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3878875.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3878875.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-33145.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-33145.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-33145.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3912020.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3879901.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3879901.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12957.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,428238.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,237717.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3200989.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3200989.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1765.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1765.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1765.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1805437.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1805437.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1805437.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1397317.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4177649.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4177649.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12839.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,529738.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1002231.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2632841.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2632841.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-29838.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-29838.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-29838.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1407936.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1407936.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1407936.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1254743.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5387698.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5387698.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6935.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,485510.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,865386.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4029867.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4029867.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,60790.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,60790.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,60790.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,53772560.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,364235.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,54136795.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,54136795.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,50167718.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5699892.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5699892.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8015.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,971340.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1360913.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6081450.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6081450.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-31847693.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-31847693.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-31847693.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,33032.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,33032.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,33032.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-37896111.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5965140.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5965140.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8176.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,536297.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,659061.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4761606.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4761606.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11937.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4943161.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4955098.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4955098.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4052.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4052.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4052.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9712652.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7838873.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7838873.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9294.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,608304.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,268373.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6952902.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6952902.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23256.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7600000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7576744.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7576744.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,104532.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,104532.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,104532.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,728374.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14499609.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14499609.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12493.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,991564.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5143965.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8351587.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8351587.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-56825.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14200000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14143175.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14143175.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,151499.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,151499.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,151499.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5943087.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-644503.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-644503.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13748.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,59621.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,812582.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8257877.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8016429.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8016429.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5633.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9944974.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20400000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10449393.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10449393.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,89350.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,89350.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,89350.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2522314.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10959948.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10959948.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6438.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-59621.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,953206.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2213873.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,14073844.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,14073844.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13737.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19827454.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9910595.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9930596.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9930596.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,192550.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,192550.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,192550.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4335798.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,13630179.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13630179.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6532.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,700720.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1925186.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,16262617.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,16262617.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4952973.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5047027.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5047027.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,256062.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,256062.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,256062.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21565706.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7929713.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7929713.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,27609.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1034094.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3300025.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12291441.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12291441.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,1.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,31658770.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,31658771.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,31658771.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,578280.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,578280.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,578280.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,44528492.0
